{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:21:34Z","timestamp":1790266894807,"version":"4.1.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Integrative oncology (IO) modalities aim to improve the quality of life of persons with cancer, including strategies to manage treatment and disease-related symptoms. As evidence increases to include IO in supportive care, interest grows globally. Understanding barriers to IO recommendation is key to facilitating its uptake.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Members of the Multinational Association of Supportive Care in Cancer (MASCC) and the Society for Integrative Oncology (SIO) were invited to complete an online survey in Fall 2023 assessing barriers to IO recommendation on a 5-point scale. Descriptive statistics assessed demographic data and general counts of scaled agreement, while logistic regression analysis evaluated perceived barriers in relation to relevant covariates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Over 80% of respondents believed that healthcare professionals\u2019 (HCP) lack of knowledge with IO and lack of insurance\/out-of-pocket costs were barriers to recommending IO. Approximately 80% agreed that lack of referral pathways was a logistical barrier and 85% reported lack of confidence in IO as an individual-level barrier. Respondents from Europe were 2.2 times more likely to agree with the perceived barrier of HCP knowledge, compared to respondents from North America (OR 2.22, 95% CI 1.05\u20134.67,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.036). Lastly, compared to general physicians, integrative professionals were more likely to report perceptions that IO would delay conventional care delivery (OR 3.62, 95% CI 1.56\u20138.43,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0003).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Results of this study highlight important barriers and facilitators of IO integration into standard supportive care globally. These findings represent perspectives from an international sample of MASCC and SIO members and may not apply to all oncology professionals. Further research is necessary to understand the global roadblocks that exist among practitioners interested in IO use.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00520-026-11020-2","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T14:41:05Z","timestamp":1784731265000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Barriers to recommendation of integrative oncology modalities in supportive care: a MASCC\/SIO survey"],"prefix":"10.1007","volume":"34","author":[{"given":"Alexandre","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia","family":"Kagramanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem","family":"Nasr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chioma","family":"Asuzu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin Ting","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Hye","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Lacey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard T.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Lustberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice M.","family":"Ohaeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Soto-Perez-de-Celis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia M.","family":"Witt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Maria","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"issue":"12","key":"11020_CR1","doi-asserted-by":"publisher","first-page":"3946","DOI":"10.3390\/jcm12123946","volume":"12","author":"G Semeniuk","year":"2023","unstructured":"Semeniuk G, Bahadini B, Ahn E, Zain J, Cheng J, Govindarajan A, Rose J, Lee RT (2023) Integrative oncology and the clinical care network: challenges and opportunities. J Clin Med 12(12):3946. https:\/\/doi.org\/10.3390\/jcm12123946","journal-title":"J Clin Med"},{"key":"11020_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1200\/JOP.18.00554","volume":"15","author":"S Latte-Naor","year":"2019","unstructured":"Latte-Naor S et al (2019) Putting integrative oncology into practice: concepts and approaches. JOP 15:7\u201314. https:\/\/doi.org\/10.1200\/JOP.18.00554","journal-title":"JOP"},{"key":"11020_CR3","doi-asserted-by":"crossref","unstructured":"Witt CM, Balneaves LG, Cardoso MJ, Cohen L, Greenlee H, Johnstone P, K\u00fcc\u00fck \u00d6, Mailman J, Mao JJ (2017) A comprehensive definition for integrative oncology. J Nat Cancer Inst Monogr 2017(52)","DOI":"10.1093\/jncimonographs\/lgx012"},{"issue":"3","key":"11020_CR4","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_431554","volume":"44","author":"K Gowin","year":"2024","unstructured":"Gowin K, Muminovic M, Zick SM, Lee RT, Lacchetti C, Mehta A (2024) Integrative therapies in cancer care: an update on the guidelines. Am Soc Clin Oncol Educ Book 44(3):e431554","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"11020_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-017-4122-5)","volume":"17","author":"H Cramer","year":"2017","unstructured":"Cramer H, Lange S, Klose P, Paul A, Dobos G (2017) Yoga for breast cancer patients and survivors: a systematic review and meta-analysis. BMC Cancer 17:1\u201313. https:\/\/doi.org\/10.1186\/s12885-017-4122-5)","journal-title":"BMC Cancer"},{"issue":"8","key":"11020_CR6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11912-018-0703-7)","volume":"20","author":"LE Carlson","year":"2018","unstructured":"Carlson LE, Zelinski E, Toivonen K, Flynn M, Qureshi M, Tu H, Piedalue K (2018) Mind-body therapies in cancer: what is the latest evidence? Curr Oncol Rep 20(8):67. https:\/\/doi.org\/10.1007\/s11912-018-0703-7)","journal-title":"Curr Oncol Rep"},{"key":"11020_CR7","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/2898719","volume":"2020","author":"L Chen","year":"2020","unstructured":"Chen L, Lin CC, Huang TW, Chien TW (2020) Efficacy of acupuncture in the management of cancer pain: a systematic review and meta-analysis. Evid Based Complementary and Alternative Medicine 2020:2898719. https:\/\/doi.org\/10.1155\/2020\/2898719","journal-title":"Evid Based Complementary and Alternative Medicine"},{"key":"11020_CR8","doi-asserted-by":"publisher","DOI":"10.1177\/1534735418823266","volume":"18","author":"SJ Grant","year":"2019","unstructured":"Grant SJ, Hunter J, Seely D, Balneaves LG, Rossi E, Bao T (2019) Integrative oncology: international perspectives. Integr Cancer Ther 18:1534735418823266","journal-title":"Integr Cancer Ther"},{"key":"11020_CR9","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_389830","volume":"43","author":"T Bao","year":"2023","unstructured":"Bao T, Greenlee H, Lopez AM, Kadro ZO, Lopez G, Carlson LE (2023) How to make evidence-based integrative medicine a part of everyday oncology practice. Am Soc Clin Oncol Educ Book 43:e389830","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"5","key":"11020_CR10","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1001\/jamaoncol.2019.0349","volume":"5","author":"NN Sanford","year":"2019","unstructured":"Sanford NN, Sher DJ, Ahn C, Aizer AA, Mahal BA (2019) Prevalence and nondisclosure of complementary and alternative medicine use in patients with cancer and cancer survivors in the United States. JAMA Oncol 5(5):735\u2013737","journal-title":"JAMA Oncol"},{"issue":"2","key":"11020_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-023-08278-1","volume":"32","author":"N Colla\u00e7o","year":"2024","unstructured":"Colla\u00e7o N et al (2024) Barriers and facilitators to integrated cancer care between primary and secondary care: a scoping review. Support Care Cancer 32(2):120. https:\/\/doi.org\/10.1007\/s00520-023-08278-1","journal-title":"Support Care Cancer"},{"issue":"1","key":"11020_CR12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1089\/imr.2021.0004","volume":"1","author":"JS Mascaro","year":"2022","unstructured":"Mascaro JS et al (2022) Examination of provider and patient knowledge, beliefs, and preferences in integrative oncology at a national cancer institute-designated comprehensive cancer center. Integr Med Rep 1(1):66\u201375. https:\/\/doi.org\/10.1089\/imr.2021.0004","journal-title":"Integr Med Rep"},{"key":"11020_CR13","doi-asserted-by":"publisher","unstructured":"Ben-Arye E et al (2012) \u201cBarriers to integration of traditional and complementary medicine in supportive cancer care of Arab patients in northern Israel\u201d. Evid Based Complement Alternat Med eCAM 2012:401867. https:\/\/doi.org\/10.1155\/2012\/401867","DOI":"10.1155\/2012\/401867"},{"issue":"12","key":"11020_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12123946","volume":"12","author":"G Semeniuk","year":"2023","unstructured":"Semeniuk G et al (2023) Integrative oncology and the clinical care network: challenges and opportunities. J Clin Med 12(12):3946. https:\/\/doi.org\/10.3390\/jcm12123946","journal-title":"J Clin Med"},{"issue":"S1","key":"11020_CR15","doi-asserted-by":"publisher","first-page":"S89","DOI":"10.1089\/acm.2020.0299","volume":"27","author":"J Hunter","year":"2021","unstructured":"Hunter J et al (2021) Barriers and facilitators to integrative oncology services in Australia: a changed mind set required. Journal of alternative and complementary medicine (New York, N.Y.) 27(S1):S89\u2013S98. https:\/\/doi.org\/10.1089\/acm.2020.0299","journal-title":"Journal of alternative and complementary medicine (New York, N.Y.)"},{"issue":"1","key":"11020_CR16","first-page":"98","volume":"21","author":"L Beatty","year":"2012","unstructured":"Beatty L, Koczwara B, Knott V, Wade T (2012) Why people choose to not use complementary therapies during cancer treatment: a focus group study. Eur J Cancer Care 21(1):98\u2013106","journal-title":"Eur J Cancer Care"},{"key":"11020_CR17","doi-asserted-by":"crossref","unstructured":"Chan A, Nasr R, Arcos D, Kagramanov D, Asuzu C, Bao T, ..., Lopez AM (2025). Evaluation of integrative oncology modalities for symptom management: a MASCC\/SIO global survey. BMC complement Med Ther 25(1):406","DOI":"10.1186\/s12906-025-05157-6"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11020-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11020-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11020-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T14:55:19Z","timestamp":1786200919000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-026-11020-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":17,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["11020"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-11020-2","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"17 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board at the University of California, Irvine (Protocol #3392), and a waiver of informed consent was granted by the IRB. Our study adhered to the Declaration of Helsinki. Active members of MASCC and\/or SIO were eligible to complete the survey.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"791"}}